Cipla, Alibaba, Political Ads: Intellectual Property

Updated on

Cipla Ltd., a Mumbai-based pharmaceutical company, has asked India’s intellectual property regulators to revoke patents covering Novartis AG’s respiratory drug Indacaterol, The Hindu newspaper reported.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.